About the bill
Read CRS Summary >
Nov 6, 1997
This is the first step in the legislative process.
Read Text »
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 2851”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2016). H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B .... Retrieved from https://www.govtrack.us/congress/bills/105/hr2851
“H.R. 2851 — 105th Congress: To prohibit application of a payment limit to a drug or biological under part B ....” www.GovTrack.us. 1997. February 6, 2016 <https://www.govtrack.us/congress/bills/105/hr2851>
|title=H.R. 2851 (105th)
|accessdate=February 6, 2016
|author=105th Congress (1997)
|date=November 6, 1997
|quote=To prohibit application of a payment limit to a drug or biological under part B ...